|
94 Companies |
|
165 Products |
|
165 Products |
|
42 Mechanisms of Action |
|
2 Trials |
|
1453 News |
|
| «12345678910111213...2930» |
- | Phase classification, Enrollment change: Differential Metabolism of Dietary Fatty Acids (clinicaltrials.gov) - Oct 12, 2017
P=N/A, N=19, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase classification: P1 --> P=N/A | N=44 --> 19
- | Trial completion: Differential Metabolism of Dietary Fatty Acids (clinicaltrials.gov) - Oct 11, 2017
P=N/A, N=19, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase classification: P1 --> P=N/A | N=44 --> 19 No longer recruiting --> Completed
- ||||||| lovastatin / Generic mfg.
Trial completion: A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED) (clinicaltrials.gov) - Oct 1, 2017
P3, N=1000, Completed, Sponsor: Merck Sharp & Dohme Corp.
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| Praluent (alirocumab) / Sanofi, Regeneron
Trial completion: Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II) (clinicaltrials.gov) - Sep 6, 2017
P3, N=233, Completed, Sponsor: Sanofi
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment closed, Trial primary completion date: Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation (clinicaltrials.gov) - Sep 1, 2017
P=N/A, N=20, Active, not recruiting, Sponsor: Tufts University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2017
- | Trial completion: WALDI: The Metabolic Effect of Walnuts in Healthy Subjects (clinicaltrials.gov) - Aug 29, 2017
P=N/A, N=180, Completed, Sponsor: Ludwig-Maximilians - University of Munich
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2017 Active, not recruiting --> Completed
- Galafold (migalastat) / Amicus
Phase classification: Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease (clinicaltrials.gov) - Aug 25, 2017
P=N/A, N=0, Available, Sponsor: Amicus Therapeutics
Active, not recruiting --> Completed Phase classification: P3 --> P=N/A
- | Trial completion, Trial primary completion date: Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent. (clinicaltrials.gov) - Aug 17, 2017
P=N/A, N=60, Completed, Sponsor: McGill University Health Center
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Apr 2015
- ||| vardenafil / Generic mfg.
Enrollment change: A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia (clinicaltrials.gov) - Aug 16, 2017
P4, N=395, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Apr 2015 N=510 --> 395
- | Trial suspension: HyTe-2: Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (clinicaltrials.gov) - Aug 8, 2017
P=N/A, N=155, Suspended, Sponsor: Coxa, Hospital for Joint Replacement
N=510 --> 395 Active, not recruiting --> Suspended
- | atorvastatin/fenofibrate (CKD-337) / Chong Kun Dang
Trial completion: CKD-337 Drug Interaction Study (clinicaltrials.gov) - Aug 8, 2017
P1, N=30, Completed, Sponsor: Chong Kun Dang Pharmaceutical
Active, not recruiting --> Suspended Not yet recruiting --> Completed
- ||| Trial completion, Trial primary completion date: An Analysis of Diabetes Control in Puerto Rico (clinicaltrials.gov) - Jul 21, 2017
P=N/A, N=600, Completed, Sponsor: Center for Diabetes Control, Inc.
Not yet recruiting --> Completed Enrolling by invitation --> Completed | Trial primary completion date: Nov 2010 --> Nov 2012
- | Targretin oral (bexarotene oral) / ReXceptor
Trial completion, Enrollment change: TgBEX: Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma (clinicaltrials.gov) - Jul 21, 2017
P4, N=10, Completed, Sponsor: Rennes University Hospital
Enrolling by invitation --> Completed | Trial primary completion date: Nov 2010 --> Nov 2012 Recruiting --> Completed | N=15 --> 10
- | Trial completion: Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease (clinicaltrials.gov) - Jul 20, 2017
P1/2, N=39, Completed, Sponsor: Oregon Health and Science University
Recruiting --> Completed | N=15 --> 10 No longer recruiting --> Completed
- | Enrollment closed, Trial primary completion date: Stress and Sugar Synergy (clinicaltrials.gov) - Jul 17, 2017
P=N/A, N=23, Active, not recruiting, Sponsor: University of California, Davis
No longer recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Dec 2018
- | Trial completion: Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=35, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Dec 2018 Recruiting --> Completed
- | Trial completion: Registry of Fabry Disease - A Multicenter Observational Study (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=100, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Analysis of the Nervous System in Patients With Fabry's Disease (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=325, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease (clinicaltrials.gov) - Jun 30, 2017
P2, N=30, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Effects of Enzyme Replacement in Gaucher's Disease (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=70, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
No longer recruiting --> Completed Recruiting --> Completed
- |||| atorvastatin / Generic mfg., fenofibrate/pravastatin / Generic mfg.
Trial primary completion date, Monotherapy, Head-to-Head: Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin (clinicaltrials.gov) - Jun 22, 2017
P3, N=366, Recruiting, Sponsor: Yooyoung Pharmaceutical Co.,Ltd.
Recruiting --> Completed Trial primary completion date: Dec 2016 --> Dec 2017
- Enrollment change, Trial primary completion date: A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=11, Completed, Sponsor: Zeltiq Aesthetics
Trial primary completion date: Dec 2016 --> Dec 2017 N=28 --> 11 | Trial primary completion date: Aug 2013 --> Jun 2017
- | Trial completion, Trial primary completion date: Outer Thigh Study With Varied Treatment Parameters (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=40, Completed, Sponsor: Zeltiq Aesthetics
N=28 --> 11 | Trial primary completion date: Aug 2013 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2017
- | Trial completion, Enrollment change, Trial primary completion date: Tissue Optimization on Cryolipolysis Procedures for Fat Layer Reduction (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=19, Completed, Sponsor: Zeltiq Aesthetics
Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2017 Active, not recruiting --> Completed | N=150 --> 19 | Trial primary completion date: Dec 2015 --> Jun 2017
- | tenofovir disoproxil fumarate / Generic mfg.
Enrollment change: Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults (clinicaltrials.gov) - Jun 7, 2017
P2, N=50, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed | N=150 --> 19 | Trial primary completion date: Dec 2015 --> Jun 2017 N=63 --> 50
- | Amevive (alefacept) / Astellas
Trial termination: Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (clinicaltrials.gov) - Jun 7, 2017
P=N/A, N=3, Terminated, Sponsor: Emory University
N=63 --> 50 Suspended --> Terminated; drug company is no longer making the drug
- | tenofovir disoproxil fumarate / Generic mfg.
Trial completion: Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults (clinicaltrials.gov) - Jun 6, 2017
P2, N=50, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Suspended --> Terminated; drug company is no longer making the drug Recruiting --> Completed
- | Phase classification: Effects of Omega-3 Fatty Acids on Markers of Inflammation (clinicaltrials.gov) - May 30, 2017
P=N/A, N=102, Completed, Sponsor: Stanford University
Recruiting --> Completed Phase classification: P2/3 --> P=N/A
- | Phase classification: Effect of Fish Oil on Plasma Triglycerides in Adults (clinicaltrials.gov) - May 30, 2017
P=N/A, N=60, Completed, Sponsor: Stanford University
Phase classification: P2/3 --> P=N/A Phase classification: P2 --> P=N/A
- |||| fluvastatin / Generic mfg.
Trial completion: Fluvastatin in Adults With Dislipidemia With History of Muscle Problems (clinicaltrials.gov) - May 16, 2017
P4, N=218, Completed, Sponsor: Novartis
Phase classification: P2 --> P=N/A No longer recruiting --> Completed
- | Trial completion: Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children (clinicaltrials.gov) - May 15, 2017
P=N/A, N=41, Completed, Sponsor: Poudre Valley Health System
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Biomarker, Enrollment change, Trial withdrawal, Trial primary completion date: Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels (clinicaltrials.gov) - May 11, 2017
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Nursing Research (NINR)
Active, not recruiting --> Completed N=122 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jul 2018 --> May 2017
- Trial withdrawal: Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients (clinicaltrials.gov) - May 8, 2017
P4, N=0, Withdrawn, Sponsor: Baxter Healthcare Corporation
N=122 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jul 2018 --> May 2017 Terminated --> Withdrawn
- | pravastatin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: OxLDL: Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome (clinicaltrials.gov) - May 8, 2017
P1, N=7, Completed, Sponsor: University of North Carolina, Chapel Hill
Terminated --> Withdrawn Active, not recruiting --> Completed | N=10 --> 7 | Trial primary completion date: Dec 2017 --> Jan 2017
- | Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: The Effect of a Coloring Prompt on Health Engagement (clinicaltrials.gov) - May 4, 2017
P=N/A, N=8711, Completed, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed | N=10 --> 7 | Trial primary completion date: Dec 2017 --> Jan 2017 Recruiting --> Completed | N=15000 --> 8711 | Initiation date: May 2014 --> May 2011 | Trial primary completion date: Dec 2016 --> Nov 2012
- tropicamide / Generic mfg.
Trial completion, Trial primary completion date: Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients (clinicaltrials.gov) - May 2, 2017
P=N/A, N=8, Completed, Sponsor: Université de Montréal
Recruiting --> Completed | N=15000 --> 8711 | Initiation date: May 2014 --> May 2011 | Trial primary completion date: Dec 2016 --> Nov 2012 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Sep 2016
- | Trial completion, Enrollment change, Trial primary completion date: Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease (clinicaltrials.gov) - Apr 28, 2017
P=N/A, N=17, Completed, Sponsor: Yale University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Sep 2016 Recruiting --> Completed | N=120 --> 17 | Trial primary completion date: Mar 2018 --> Feb 2017
- Trial primary completion date: EDP8: Enhanced Multicenter Dietary Portfolio Study (clinicaltrials.gov) - Apr 26, 2017
P=N/A, N=0, Withdrawn, Sponsor: St. Michael's Hospital, Toronto
Recruiting --> Completed | N=120 --> 17 | Trial primary completion date: Mar 2018 --> Feb 2017 Trial primary completion date: Sep 2013 --> Oct 2014
- | Trial primary completion date: Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=10, Active, not recruiting, Sponsor: Tufts University
Trial primary completion date: Sep 2013 --> Oct 2014 Trial primary completion date: Dec 2015 --> Apr 2015
- | Preclinical, Trial primary completion date: Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=6, Recruiting, Sponsor: Tufts University
Trial primary completion date: Dec 2015 --> Apr 2015 Trial primary completion date: Oct 2015 --> Jun 2016
- | pravastatin / Generic mfg.
Trial primary completion date: OxLDL: Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome (clinicaltrials.gov) - Apr 18, 2017
P1, N=10, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Oct 2015 --> Jun 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- | Enrollment closed, Trial primary completion date: Screening for Fabry Disease in a Pediatric Population at Risk (clinicaltrials.gov) - Apr 17, 2017
P=N/A, N=2000, Active, not recruiting, Sponsor: University Hospital Heidelberg
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Jul 2017
- || Tredaptive (niacin controlled release/laropiprant) / Merck (MSD)
Trial primary completion date: MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) (clinicaltrials.gov) - Apr 7, 2017
P2, N=407, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Jul 2017 Trial primary completion date: Jan 2007 --> Jul 2005
- | Enrollment change, Trial primary completion date: Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C (clinicaltrials.gov) - Apr 4, 2017
P=N/A, N=19, Terminated, Sponsor: Vanderbilt University Medical Center
Trial primary completion date: Jan 2007 --> Jul 2005 N=10 --> 19 | Trial primary completion date: Dec 2015 --> Nov 2014
- | Fabrazyme (agalsidase beta) / Sanofi, Replagal (agalsidase alfa) / Samaritan Pharma, Takeda
Trial completion: Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta (clinicaltrials.gov) - Apr 4, 2017
P=N/A, N=30, Completed, Sponsor: O & O Alpan LLC
N=10 --> 19 | Trial primary completion date: Dec 2015 --> Nov 2014 Active, not recruiting --> Completed
- | Trial completion, Trial primary completion date: Exploration of Immunity in Gaucher Disease (clinicaltrials.gov) - Apr 4, 2017
P=N/A, N=33, Completed, Sponsor: O & O Alpan LLC
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> May 2016
- || metformin / Generic mfg., fenofibrate / Generic mfg.
Trial primary completion date: The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study (clinicaltrials.gov) - Mar 20, 2017
P2, N=124, Completed, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> May 2016 Trial primary completion date: Mar 2008 --> Dec 2007
- | Enrollment change: Elevated Serum HDL in Four Generations of a Nashville Family (clinicaltrials.gov) - Mar 20, 2017
P=N/A, N=3, Terminated, Sponsor: Vanderbilt University Medical Center
Trial primary completion date: Mar 2008 --> Dec 2007 N=26 --> 3
- | Trial completion, Enrollment change, Trial primary completion date: The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients (clinicaltrials.gov) - Mar 17, 2017
P=N/A, N=43, Completed, Sponsor: Clinical Research Center for End Stage Renal Disease, Korea
N=26 --> 3 Recruiting --> Completed | N=1222 --> 43 | Trial primary completion date: Feb 2015 --> Nov 2015
- || Livalo (pitavastatin) / Kowa, Eli Lilly
Trial primary completion date: SIPHON: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (clinicaltrials.gov) - Mar 10, 2017
P4, N=313, Active, not recruiting, Sponsor: JW Pharmaceutical
Recruiting --> Completed | N=1222 --> 43 | Trial primary completion date: Feb 2015 --> Nov 2015 Trial primary completion date: Aug 2015 --> May 2016